A citation-based method for searching scientific literature

Alexander Drilon, Chelsea Jenkins, Sudarshan Iyer, Adam Schoenfeld, Clare Keddy, Monika A Davare. Nat Rev Clin Oncol 2021
Times Cited: 37







List of co-cited articles
327 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy.
Balázs Jóri, Stefanie Schatz, Len Kaller, Bettina Kah, Julia Roeper, Hayat O Ramdani, Linda Diehl, Petra Hoffknecht, Christian Grohé, Frank Griesinger,[...]. Cancers (Basel) 2021
3
33


Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.
Jacob J Chabon, Andrew D Simmons, Alexander F Lovejoy, Mohammad S Esfahani, Aaron M Newman, Henry J Haringsma, David M Kurtz, Henning Stehr, Florian Scherer, Chris A Karlovich,[...]. Nat Commun 2016
410
2

Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors.
Xiaojing Du, Biwei Yang, Quanlin An, Yehuda G Assaraf, Xin Cao, Jinglin Xia. Innovation (N Y) 2021
15
6

Emerging EML4-ALK Variant 5 as a Concurrent Resistance Mechanism to Osimertinib in a Patient With EGFR E19del/T790M NSCLC.
Yan Yan, Guozhong Jiang, Weijie Ma, Tianhong Li, Liping Wang. Clin Lung Cancer 2020
2
50




Squamous cell carcinoma transformation from adenocarcinoma as an acquired resistance after the EGFR TKI therapy in (EGFR-mutated) non-small cell lung cancer.
Shinji Shinohara, Yoshinobu Ichiki, Yukiko Fukuichi, Yohei Honda, Masatoshi Kanayama, Akihiro Taira, Yusuke Nabe, Taiji Kuwata, Masaru Takenaka, Soichi Oka,[...]. J Thorac Dis 2018
8
12

Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system.
T Iwahara, J Fujimoto, D Wen, R Cupples, N Bucay, T Arakawa, S Mori, B Ratzkin, T Yamamoto. Oncogene 1997
496
2

Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus.
Kavita Y Sarin, Bryan K Sun, Charles D Bangs, Athena Cherry, Susan M Swetter, Jinah Kim, Paul A Khavari. JAMA Dermatol 2013
26
3

BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study.
Eleni Makrodouli, Eftychia Oikonomou, Michal Koc, Ladislav Andera, Takehiko Sasazuki, Senji Shirasawa, Alexander Pintzas. Mol Cancer 2011
101
2

The complex management of atypical Spitz tumours.
Daniela Massi, Vincenzo De Giorgi, Mario Mandalà. Pathology 2016
10
10



Anaplastic lymphoma kinase proteins in growth control and cancer.
K Pulford, S W Morris, F Turturro. J Cell Physiol 2004
170
2

Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition.
H S Kim, M Jung, H N Kang, H Kim, C-W Park, S-M Kim, S J Shin, S H Kim, S G Kim, E K Kim,[...]. Oncogene 2017
50
2

Proliferative nodule in small congenital melanocytic naevus after childhood.
Takahiro Kiyohara, Takahiro Sawai, Masanobu Kumakiri. Acta Derm Venereol 2012
5
20

Regulation of c-Met-dependent gene expression by PTEN.
Roger Abounader, Thomas Reznik, Carlo Colantuoni, Francisco Martinez-Murillo, Eliot M Rosen, John Laterra. Oncogene 2004
48
2

RAS isoforms and mutations in cancer at a glance.
G Aaron Hobbs, Channing J Der, Kent L Rossman. J Cell Sci 2016
405
2

Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.
B C Bastian, P E LeBoit, H Hamm, E B Bröcker, D Pinkel. Cancer Res 1998
384
2


BRAF fusion Spitz neoplasms; clinical morphological, and genomic findings in six cases.
Daniel Kim, Ayesha U Khan, Elsy V Compres, Bin Zhang, Joel C Sunshine, Victor L Quan, Pedram Gerami. J Cutan Pathol 2020
3
33

The COOH-terminal domain of wild-type Cot regulates its stability and kinase specific activity.
Maria Luisa Gándara, Pilar López, Raquel Hernando, José G Castaño, Susana Alemany. Mol Cell Biol 2003
38
2

Morphologic features in a series of 352 Spitz melanocytic proliferations help predict their oncogenic drivers.
Thibault Kervarrec, Daniel Pissaloux, Franck Tirode, Mahtab Samimi, Julien Jacquemus, Christine Castillo, Arnaud de la Fouchardière. Virchows Arch 2022
3
33

Spitz nevus with a novel TFG-NTRK2 fusion: The first case report of NTRK2-rearranged Spitz/Reed nevus.
Keisuke Goto, Daniel Pissaloux, Franck Tirode, Arnaud de la Fouchardière. J Cutan Pathol 2021
5
20

SP174 Antibody Lacks Specificity for NRAS Q61R and Cross-Reacts With HRAS and KRAS Q61R Mutant Proteins in Malignant Melanoma.
Anna Felisiak-Goląbek, Shingo Inaguma, Artur Kowalik, Bartosz Wasąg, Zeng-Feng Wang, Sebastian Zięba, Liliana Pięciak, Janusz Ryś, Janusz Kopczynski, Maarit Sarlomo-Rikala,[...]. Appl Immunohistochem Mol Morphol 2018
14
7

Pathologic Characteristics of Spitz Melanoma With MAP3K8 Fusion or Truncation in a Pediatric Cohort.
Scott Newman, Alberto Pappo, Susana Raimondi, Jinghui Zhang, Raymond Barnhill, Armita Bahrami. Am J Surg Pathol 2019
8
12

Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi.
Ryan P Bender, Matthew J McGinniss, Paula Esmay, Elsa F Velazquez, Julie Dr Reimann. Mod Pathol 2013
30
3

Update in genetic susceptibility in melanoma.
Miriam Potrony, Celia Badenas, Paula Aguilera, Joan Anton Puig-Butille, Cristina Carrera, Josep Malvehy, Susana Puig. Ann Transl Med 2015
99
2

Spitz nevi and Spitzoid melanomas: exome sequencing and comparison with conventional melanocytic nevi and melanomas.
Rossitza Lazova, Natapol Pornputtapong, Ruth Halaban, Marcus Bosenberg, Yalai Bai, Hao Chai, Michael Krauthammer. Mod Pathol 2017
34
2

Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase.
A Salmeron, T B Ahmad, G W Carlile, D Pappin, R P Narsimhan, S C Ley. EMBO J 1996
261
2

A case report of atypical Spitz tumor harboring a novel MLPH-ALK gene fusion with discordant ALK immunohistochemistry results.
Masakazu Fujimoto, Yuki Togashi, Ibu Matsuzaki, Satoko Baba, Kengo Takeuchi, Yutaka Inaba, Masatoshi Jinnin, Shin-Ichi Murata. Hum Pathol 2018
6
16

Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Thomas Wiesner, Heinz Kutzner, Lorenzo Cerroni, Martin C Mihm, Klaus J Busam, Rajmohan Murali. Pathology 2016
86
2

Unclassified sclerosing malignant melanomas with AKAP9-BRAF gene fusion: a report of two cases and review of BRAF fusions in melanocytic tumors.
Emilie Perron, Daniel Pissaloux, Angela Neub, Daniel Hohl, Marie Dominique Tartar, Laurent Mortier, Laurent Alberti, Arnaud de la Fouchardiere. Virchows Arch 2018
12
8

The landscape of fusion transcripts in spitzoid melanoma and biologically indeterminate spitzoid tumors by RNA sequencing.
Gang Wu, Raymond L Barnhill, Seungjae Lee, Yongjin Li, Ying Shao, John Easton, James Dalton, Jinghui Zhang, Alberto Pappo, Armita Bahrami. Mod Pathol 2016
41
2

The T1796A mutation of the BRAF gene is absent in Spitz nevi.
Gabriele Palmedo, Markus Hantschke, Arno Rütten, Thomas Mentzel, Heino Hügel, Michael J Flaig, Amir S Yazdi, Christian A Sander, Heinz Kutzner. J Cutan Pathol 2004
50
2

Corresponding anaplastic lymphoma kinase-tropomyosin 3 (ALK-TPM3) fusion in a patient with a primary cutaneous anaplastic large-cell lymphoma and a Spitz nevus.
Rutger C Melchers, Rein Willemze, Remco van Doorn, Patty M Jansen, Arjen H G Cleven, Nienke Solleveld, Maarten H Vermeer, Koen D Quint. JAAD Case Rep 2019
3
33

The role of gene fusions in melanocytic neoplasms.
Victor L Quan, Elnaz Panah, Bin Zhang, Katherine Shi, Lauren S Mohan, Pedram Gerami. J Cutan Pathol 2019
21
4

Fusion of ALK to the melanophilin gene MLPH in pediatric Spitz nevi.
Catherine T Chung, Paula Marrano, David Swanson, Brendan C Dickson, Paul Scott Thorner. Hum Pathol 2019
6
16

Beyond the BRAFV600E hotspot: biology and clinical implications of rare BRAF gene mutations in melanoma patients.
G Richtig, C Hoeller, K Kashofer, A Aigelsreiter, A Heinemann, L N Kwong, M Pichler, E Richtig. Br J Dermatol 2017
30
3

Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological-genetic correlations.
Aurelie Houlier, Daniel Pissaloux, Ingrid Masse, Franck Tirode, Marie Karanian, Laura B Pincus, Timothy H McCalmont, Philip E LeBoit, Boris C Bastian, Iwei Yeh,[...]. Mod Pathol 2020
19
5

BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance.
P D Da Forno, J H Pringle, A Fletcher, M Bamford, L Su, L Potter, G Saldanha. Br J Dermatol 2009
55
2

Pigmented nevi, benign juvenile melanoma and circumscribed precancerous melanosis.
M B SULZBERGER, A W KOPF, V H WITTEN. Postgrad Med 1959
9
11


ROS1 pattern of immunostaining in 11 cases of spitzoid tumour: comparison with histopathological, fluorescence in-situ hybridisation and next-generation sequencing analysis.
Anna Maria Cesinaro, Graziana Gallo, Samantha Manfredini, Antonino Maiorana, Stefania Raffaella Bettelli. Histopathology 2021
1
100

NTRK Gene Fusion Detection in Atypical Spitz Tumors.
Rocco Cappellesso, Filippo Nozzoli, Federica Zito Marino, Sara Simi, Francesca Castiglione, Vincenzo De Giorgi, Carlo Cota, Rebecca Senetta, Giosuè Scognamiglio, Anna Maria Anniciello,[...]. Int J Mol Sci 2021
3
33

Lack of BRAF mutations in Spitz nevi.
Melissa Gill, Neil Renwick, David N Silvers, Jülide Tok Celebi. J Invest Dermatol 2004
48
2

Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms.
Liaqat Ali, Thomas Helm, Richard Cheney, Jeffrey Conroy, Sheilla Sait, Joan Guitart, Pedram Gerami. Int J Clin Exp Pathol 2010
53
2

Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase.
J Yan, S Roy, A Apolloni, A Lane, J F Hancock. J Biol Chem 1998
378
2


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.